Magic Mushrooms May Prevent Chemo's Painful Side Effects

A drug once banned for recreational use might soon help cancer patients keep their quality of life during treatment.

Researchers at MD Anderson Cancer Center found that psilocybin, the active compound in magic mushrooms, protected mice from one of chemotherapy's most painful side effects: peripheral neuropathy. Just two doses before chemo kept nerve function intact while still allowing the drugs to destroy tumors.

Peripheral neuropathy causes numbness, tingling, and pain in hands and feet. It happens because chemotherapy damages the body's longest nerve cells while attacking cancer. For many patients, the condition becomes so severe they must stop treatment early or live with permanent nerve damage.

The MD Anderson team discovered something remarkable about how psilocybin works. Nerve cells need tiny power plants called mitochondria to travel down their length, delivering energy where it's needed. Chemotherapy disrupts this movement, starving nerve endings until they die.

Psilocybin keeps those mitochondria moving normally. The protective effect appeared in mouse studies, human nerve tissue samples, and nerve cells grown in laboratories. Each test pointed to the same conclusion: this compound shields nerves without interfering with cancer treatment.

This isn't psilocybin's first medical comeback story. MDMA was used in psychotherapy during the 1970s before becoming a party drug. LSD treated depression and alcoholism before recreational use overshadowed its medical roots. Both drugs were originally created for legitimate medical purposes, not to alter consciousness.

Now MD Anderson is launching NeuroGuard, a phase two clinical trial enrolling 83 adults with breast, colorectal, or head and neck cancers. The study will test whether the same nerve protection seen in mice translates to humans receiving chemotherapy.

Why This Inspires

This research represents a turning point in how we think about both cancer care and substances society has dismissed. Scientists are looking past stigma to find real solutions for people suffering through treatment.

If successful, psilocybin could mean patients complete their full chemotherapy course without debilitating pain. They could avoid permanent nerve damage that makes simple tasks like buttoning a shirt or walking downstairs feel impossible.

The trial results could arrive within the next few years, potentially opening a new chapter where life-saving treatment doesn't force patients to choose between survival and quality of life.